Evidence map›Paper›PMID 27030368›Full record

ArticleBiochemistry2016

Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease.

Xin Hu, Jaimee R Compton, Dagmar H Leary, Mark A Olson, Michael S Lee, Jonah Cheung, Wenjuan Ye, Mark Ferrer, Noel Southall, Ajit Jadhav and 4 more

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Xin HuNIH Chemical Genomics Center, National Center for Advancing Translational Sciences , Rockville, Maryland 20850, United States.
Jaimee R ComptonNova Research, Inc. , Alexandria, Virginia 22308, United States.
Dagmar H LearyCenter for Bio/molecular Science and Engineering, U.S. Naval Research Laboratory , Washington, D.C. 20375, United States.
Mark A OlsonUnited States Army Medical Research Institute of Infectious Diseases , Frederick, Maryland 21702, United States.
Michael S LeeUnited States Army Medical Research Institute of Infectious Diseases , Frederick, Maryland 21702, United States.
Jonah CheungNew York Structural Biology Center , New York, New York 10027, United States.
Wenjuan YeNIH Chemical Genomics Center, National Center for Advancing Translational Sciences , Rockville, Maryland 20850, United States.
Mark FerrerNIH Chemical Genomics Center, National Center for Advancing Translational Sciences , Rockville, Maryland 20850, United States.
Noel SouthallNIH Chemical Genomics Center, National Center for Advancing Translational Sciences , Rockville, Maryland 20850, United States.
Ajit JadhavNIH Chemical Genomics Center, National Center for Advancing Translational Sciences , Rockville, Maryland 20850, United States.
Elaine M MorazzaniUnited States Army Medical Research Institute of Infectious Diseases , Frederick, Maryland 21702, United States.
Pamela J GlassUnited States Army Medical Research Institute of Infectious Diseases , Frederick, Maryland 21702, United States.
Juan MaruganNIH Chemical Genomics Center, National Center for Advancing Translational Sciences , Rockville, Maryland 20850, United States.
Patricia M LeglerCenter for Bio/molecular Science and Engineering, U.S. Naval Research Laboratory , Washington, D.C. 20375, United States.
National Center for Advancing Translational Sciences · USUnited States Army Medical Research Institute of Infectious Diseases · USUnited States Naval Research Laboratory · USNew York Structural Biology Center · USNova Research Company (United States) · US

Funding

Small molecule screening programZ01HG200319 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI AUSTIN, CHRISTOPHER P · 2004 to 2008
$32.3M
Identification of Novel Antivirals against Venezuelan Equine Encephalitis Virus (VEEV)ZIATR000266 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MARUGAN, JUAN · 2016 to 2017
$82k
Intramural NIH HHS Z01 HG200319
6 · The paper itself

Abstract

The Venezuelan equine encephalitis virus (VEEV) nonstructural protein 2 (nsP2) cysteine protease (EC 3.4.22.-) is essential for viral replication and is involved in the cytopathic effects (CPE) of the virus. The VEEV nsP2 protease is a member of MEROPS Clan CN and characteristically contains a papain-like protease linked to an S-adenosyl-l-methionine-dependent RNA methyltransferase (SAM MTase) domain. The protease contains an alternative active site motif, (475)NVCWAK(480), which differs from papain's (CGS(25)CWAFS), and the enzyme lacks a transition state-stabilizing residue homologous to Gln-19 in papain. To understand the roles of conserved residues in catalysis, we determined the structure of the free enzyme and the first structure of an inhibitor-bound alphaviral protease. The peptide-like E64d inhibitor was found to bind beneath a β-hairpin at the interface of the SAM MTase and protease domains. His-546 adopted a conformation that differed from that found in the free enzyme; one or both of the conformers may assist in leaving group departure of either the amine or Cys thiolate during the catalytic cycle. Interestingly, E64c (200 μM), the carboxylic acid form of the E64d ester, did not inhibit the nsP2 protease. To identify key residues involved in substrate binding, a number of mutants were analyzed. Mutation of the motif residue, N475A, led to a 24-fold reduction in kcat/Km, and the conformation of this residue did not change after inhibition. N475 forms a hydrogen bond with R662 in the SAM MTase domain, and the R662A and R662K mutations both led to 16-fold decreases in kcat/Km. N475 forms the base of the P1 binding site and likely orients the substrate for nucleophilic attack or plays a role in product release. An Asn homologous to N475 is similarly found in coronaviral papain-like proteases (PLpro) of the Severe Acute Respiratory Syndrome (SARS) virus and Middle East Respiratory Syndrome (MERS) virus. Mutation of another motif residue, K480A, led to a 9-fold decrease in kcat and kcat/Km. K480 likely enhances the nucleophilicity of the Cys. Consistent with our substrate-bound models, the SAM MTase domain K706A mutation increased Km 4.5-fold to 500 μM. Within the β-hairpin, the N545A mutation slightly but not significantly increased kcat and Km. The structures and identified active site residues may facilitate the discovery of protease inhibitors with antiviral activity.

Indexed as

Amino Acid SequenceBinding SitesCatalytic DomainCrystallography, X-RayCysteine EndopeptidasesEncephalitis Virus, Venezuelan EquineHydrolysisKineticsModels, MolecularMutationPapainProtein ConformationS-AdenosylmethionineSequence Homology, Amino AcidViral Nonstructural ProteinsCysteine EndopeptidasesnsP2 proteinasePapainS-AdenosylmethionineViral Nonstructural Proteins

Identifiers

PMID27030368
PMCPMC5290728
OpenAlexW2325826566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.